These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15588519)

  • 1. Rejuvenation of visual functions in older adult drivers and drivers with cataract during a short-term administration of N-acetylcarnosine lubricant eye drops.
    Babizhayev MA
    Rejuvenation Res; 2004; 7(3):186-98. PubMed ID: 15588519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population.
    Babizhayev MA; Burke L; Micans P; Richer SP
    Clin Interv Aging; 2009; 4():31-50. PubMed ID: 19503764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
    Babizhayev MA; Kasus-Jacobi A
    Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients.
    Babizhayev MA; Micans P; Guiotto A; Kasus-Jacobi A
    Am J Ther; 2009; 16(6):517-33. PubMed ID: 19487926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cataract halos: a driving hazard in aging populations. Implication of the Halometer DG test for assessment of intraocular light scatter.
    Babizhayev MA; Minasyan H; Richer SP
    Appl Ergon; 2009 May; 40(3):545-53. PubMed ID: 18814857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique.
    Babizhayev MA; Yegorov YE
    Recent Pat Drug Deliv Formul; 2016; 10(2):82-129. PubMed ID: 26084629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of N-acetylcarnosine in the treatment of cataracts.
    Babizhayev MA; Deyev AI; Yermakova VN; Semiletov YA; Davydova NG; Doroshenko VS; Zhukotskii AV; Goldman IM
    Drugs R D; 2002; 3(2):87-103. PubMed ID: 12001824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts.
    Babizhayev MA; Deyev AI; Yermakova VN; Semiletov YA; Davydova NG; Kurysheva NI; Zhukotskii AV; Goldman IM
    Peptides; 2001 Jun; 22(6):979-94. PubMed ID: 11390029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glare disability and driving safety.
    Babizhayev MA
    Ophthalmic Res; 2003; 35(1):19-25. PubMed ID: 12566859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA
    Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcarnosine (NAC) drops for age-related cataract.
    Dubois VD; Bastawrous A
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009493. PubMed ID: 28245346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataract in traffic.
    Mäntyjärvi M; Tuppurainen K
    Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):278-82. PubMed ID: 10208259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications.
    Babizhayev MA; Guiotto A; Kasus-Jacobi A
    J Drug Target; 2009 Jan; 17(1):36-63. PubMed ID: 19037813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
    Babizhayev MA
    Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual risk factors for crash involvement in older drivers with cataract.
    Owsley C; Stalvey BT; Wells J; Sloane ME; McGwin G
    Arch Ophthalmol; 2001 Jun; 119(6):881-7. PubMed ID: 11405840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of intraocular absorption and drug metabolism of N-acetylcarnosine lubricant eye drops: drug interaction with sight threatening lipid peroxides in the treatment for age-related eye diseases.
    Babizhayev MA
    Drug Metabol Drug Interact; 2009; 24(2-4):275-323. PubMed ID: 20408504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, population-based study of the role of visual impairment in motor vehicle crashes among older drivers: the SEE study.
    Rubin GS; Ng ES; Bandeen-Roche K; Keyl PM; Freeman EE; West SK
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1483-91. PubMed ID: 17389475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nighttime Driving in Older Adults: Effects of Glare and Association With Mesopic Visual Function.
    Kimlin JA; Black AA; Wood JM
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2796-2803. PubMed ID: 28564700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.
    Babizhayev MA
    Drug Dev Ind Pharm; 2008 Oct; 34(10):1071-89. PubMed ID: 18777243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vision and driving status of older Australians with cataract: an investigation of public hospital waiting lists.
    Keay L; Palagyi A; Do V; White A; Lamoureux E; Ivers RQ; Pesudovs K; Stapleton F; Boufous S; McCluskey P
    Clin Exp Optom; 2016 Sep; 99(5):449-55. PubMed ID: 27452648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.